Shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Free Report) are scheduled to reverse split on Monday, September 25th. The 1-5 reverse split was announced on Friday, September 22nd. The number of shares owned by shareholders will be adjusted after the market closes on Friday, September 22nd. Neoleukin Therapeutics Trading Down 1.6 % Shares of NLTX […]
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Charlie Trippodo turned 8 years old last month. That’s another year trapped in a body that won’t let her walk or talk. But recent trial studies in gene therapy have
NEW YORK, Aug. 22, 2023 /PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or.
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) Director Bros. Advisors Lp Baker acquired 1,888,800 shares of the stock in a transaction dated Tuesday, August 15th. The stock was bought at an average cost of $0.63 per share, with a total value of $1,189,944.00. Following the completion of the purchase, the director now directly owns […]